Committees
Members of the Organizing Committee (OC) frequently convene to discuss the scientific program of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts.
The members of Scientific Committee (SC) assist the Organizing Committee by providing suggestions for speakers and topics. In addition, members of the Scientific Committee actively participate in reviewing the submitted abstracts.
Organizing Committee:
-
Jan Albert MD
Jan Albert MD Jan Albert is a professor in infectious disease control especially virology at the Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, and a senior consultant in clinical virology at the Department of Microbiology at the Karolinska University Hospital, Stockholm, Sweden. Jan Albert obtained his degree as MD at Karolinska Institutet in 1983 and PhD at Karolinska Institutet in 1990. He became specialist in Clinical Virology in 1990, ...
-
Charles Boucher MD, PhD
Dr. Boucher, MD, PhD, is Professor in the Department of Virology Erasmus Medical Center, Erasmus University Rotterdam, The Netherlands. Dr Boucher received his medical degree cum laude from the Faculty of Medicine of the University of Amsterdam, The Netherlands. Specializing in medical microbiology, he also received a PhD degree from that institution. Since then, Dr Boucher has been a research assistant at the University of Amsterdam and a visiting fellow at Wellcome Research Laboratories in Beckenham, England. ...
-
Myron Cohen MD
Myron S. Cohen MD is the J. Herbert Bate Distinguished Professor of Medicine, Microbiology and Immunology and Public Health at the University of North Carolina at Chapel Hill. He is Associate Vice Chancellor for Medical Affairs-Global Health. Dr. Cohen received his BS degree (Magna Cum Laude) from the University of Illinois, Champaign-Urbana. He received an MD degree from Rush Medical College, Chicago Illinois. He completed an Infectious Disease Fellowship at Yale University. ...
-
Walid Heneine PhD
Walid Heneine, PhD is currently the Team Lead of non-HIV Surveillance, Drug Resistance, and Antiretroviral Prophylaxis, at the Laboratory Branch, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention. His research focuses on evaluating the efficacy of antiretroviral prophylaxis for HIV prevention using monkey models of rectal and vaginal transmission and identifying effective modalities that can inform clinical trial designs for oral and topical prophylaxis. ...
-
Eric Hunter PhD
Eric Hunter PhD, is Professor in the Department of Pathology and Laboratory Medicine at Emory University, Atlanta, GA. He is Co-Director of the Emory Center for AIDS Research and a Georgia Research Alliance Eminent Scholar. Dr. Hunter’s career has included undergraduate studies in bacteriology at Birmingham University, England, and graduate work in tumor immunology carried out at the Imperial Cancer Research Fund & Brunel University, London, England. ...
-
Phyllis Kanki DVM, DSc (Chair 2011)
Phyllis Kanki DVM, DSc has been a professor of Immunology and Infectious Disease at the Harvard School of Public Health since 1999. A virologist with recognized expertise in the pathogenesis and molecular epidemiology of HIV in Africa, she has led AIDS research programs in Senegal for over 20 years. Collaborative studies with the University Cheikh Anta Diop, focused on the identification and reduced transmission of HIV-2, ...
Bonnie Mathieson PhD
Bonnie Mathieson, PhD - NIH, USA
Photo and bio will follow
-
Gabriella Scarlatti MD, PhD (Chair 2011)
Gabriella Scarlatti, MD, PhD is head of the research unit Viral Evolution and Transmission at the San Raffaele Scientific Institute in Milan, Italy, and Professor at the Microbiology and Tumorbiology Center, Karolinska Institutet, Stockholm, Sweden. She has been studying the pathogenic mechanisms of mother-to-child HIV-1 transmission and paediatric HIV/AIDS, introducing in the early 90ies the concept of virus phenotypic and genotypic evolution and selection during transmission. ...
-
Ron Swanstrom MD, PhD (Chair 2011)
Ron Swanstrom MD, PhDhas studied HIV since 1986 with a special interest in using viral sequence variation as a tool to identify a changing selective environment. This approach is especially relevant for the study of the viral env gene, since its protein product is the target of host neutralizing antibodies and the determinant of viral entry phenotype. ...
-
Mark Wainberg MD
Mark A. Wainberg MD is Professor of Medicine and Microbiology and Immunology at McGill University in Montreal, Canada, where he also serves as Director of the McGill University AIDS Centre. Dr. Wainberg is an internationally recognized scientist in the field of HIV/AIDS. He served as President of the International AIDS Society between 1998-2000 with responsibilities that included organization of the XIIIth International Congress on AIDS in Durban, South Africa, 2000. ...
-
Annemarie Wensing MD, PhD
Annemarie Wensing, MD, PhD is a Virologist at the University Medical Center Utrecht. She is the clinical supervisor of the HIV unit at the department of Virology which serves as a WHO reference laboratory for HIV resistance testing. As clinical virology consultant she advises infectious disease specialists in multiple HIV-centers on their choice of antiretroviral regimen. Her research focuses on transmission and ...